Cargando…
Serum Glial Fibrillary Acidic Protein: A Surrogate Marker of the Activity of Multiple Sclerosis
OBJECTIVE: Multiple sclerosis (MS) is a neurodegenerative disorder with various clinical types. Glial fibrillary acidic protein (GFAP) is significantly elevated in the cerebrospinal fluid (CSF) of MS patients compared with that of healthy controls. The aim of this study is to evaluate serum levels o...
Autores principales: | Sharquie, Inas K., Gawwam, Gheyath AL, Abdullah, Shatha F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Istanbul Medeniyet University
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584269/ https://www.ncbi.nlm.nih.gov/pubmed/33110673 http://dx.doi.org/10.5222/MMJ.2020.48265 |
Ejemplares similares
-
Serum Glutamate Is a Predictor for the Diagnosis of Multiple Sclerosis
por: Al Gawwam, Gheyath, et al.
Publicado: (2017) -
Serum levels of glial fibrillary acidic protein in patients with amyotrophic lateral sclerosis
por: Verde, Federico, et al.
Publicado: (2022) -
Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation
por: Jiang, Xiaotong, et al.
Publicado: (2023) -
Clinical utility of serum glial fibrillary acidic protein in glial neoplasm
por: Yadav, Nidhi, et al.
Publicado: (2022) -
Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light
por: Wessels, Mark HJ, et al.
Publicado: (2023)